Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial of pembrolizumab plus pelareorep in advanced pancreatic cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating nab-paclitaxel and gemcitabine hydrochloride followed by radiation therapy prior to surgery in resectable pancreati…
-
CLINICAL_TRIALS trial_result · 2020-12-31Clinical Trial Update: First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma. [Phase 1, Phase 2]
A clinical trial update covering first-line treatment for metastatic pancreatic adenocarcinoma across Phase 1 and Phase 2, with completed st…
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating Everolimus (RAD001) in combination with Gemcitabine for advanced or metastatic pancreatic adenocarcino…
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE) [Phase 3]
Phase 3 trial evaluating ibrutinib plus nab-paclitaxel and gemcitabine in first-line metastatic pancreatic adenocarcinoma completed with pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating a combination regimen of capecitabine, bevacizumab, and radiation followed by gemcitabine and bevacizumab for local…
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating second-line treatment with FOLFIRI or modified FOLFIRI plus Veliparib in metastatic pancreatic cancer; results were…
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating GTX (gemcitabine/taxotere/xeloda) with cisplatin and irinotecan in metastatic pancreatic adenocarcinoma;…
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: Trial of Curcumin in Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating curcumin in advanced pancreatic cancer has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial of cabozantinib and erlotinib for metastatic pancreatic adenocarcinoma with EGFR and c-Met co-expression was terminat…
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX [Phase 3]
Phase 3 trial comparing FOLFOX to Gemcitabine in metastatic pancreatic cancer patients not fit for FOLFIRINOX.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating pancreatic enzyme replacement after adjuvant chemotherapy in resected pancreatic adenocarcinoma was terminated; res…
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating ibritinib in combination with gemcitabine and nab-paclitaxel for metastatic pancreatic adenocarcinoma; study comp…
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer [Phase 2]
Phase 2 trial comparing Nab-paclitaxel with gemcitabine to gemcitabine with tegafur as adjuvant therapy after radical resection of pancreati…
-
CLINICAL_TRIALS trial_result · 2020-05-06Clinical Trial Update: FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating FOLFIRINOX followed by ipilimumab with a pancreatic tumor vaccine in metastatic pancreatic cancer has completed and…
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: 4D-CT for Pancreatic Adenocarcinoma in Radiotherapy Simulation
A completed clinical trial evaluating 4D-CT for radiotherapy simulation in pancreatic adenocarcinoma; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas [Phase 1, Phase 2]
A dose-escalation study of AZD1775 with gemcitabine and radiation for unresectable pancreatic adenocarcinoma completed, with results posted …
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update for S1313 evaluating PEGPH20 in newly diagnosed metastatic pancreatic cancer (Phase 1/2) has completed with posted res…
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas [Phase 2]
Phase II trial evaluating preoperative chemo with radiation for borderline unresectable pancreatic adenocarcinoma; study terminated with res…
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial update on neoadjuvant modified FOLFIRINOX for borderline resectable pancreatic cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy plus stereotactic body radiation therapy and nelfinavir mesylate in locally advanced pancreat…
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating BC-819 (a therapeutic DNA plasmid) with gemcitabine in locally advanced pancreatic adenocarcinoma was terminated wi…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab [Phase 2]
Phase 2 trial assessing GVAX Pancreas Vaccine (with Cyclophosphamide) and CRS-207 with or without nivolumab in previously treated metastatic…
-
CLINICAL_TRIALS trial_result · 2019-07-25Clinical Trial Update: Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy [Phase 3]
Phase 3 trial update on safety and efficacy of clopidogrel in locally advanced and metastatic pancreatic adenocarcinoma treated with chemoth…
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial of regorafenib plus gemcitabine in metastatic pancreatic cancer (metastatic pancreatic adenocarcinoma) has been terminated wit…